{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:08:03Z","timestamp":1794049683244,"version":"4.8.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"8","content-domain":{"domain":["europeanneuropsychopharmacology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.euroneuro.2012.10.006","type":"journal-article","created":{"date-parts":[[2012,11,21]],"date-time":"2012-11-21T06:02:38Z","timestamp":1353477758000},"page":"852-864","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Dysregulated 5-HT2A receptor binding in postmortem frontal cortex of schizophrenic subjects"],"prefix":"10.1016","volume":"23","author":[{"given":"Carolina","family":"Muguruza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Umali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F.","family":"Callado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Javier","family":"Meana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Gonz\u00e1lez-Maeso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2012.10.006_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1192\/bjp.108.452.95","article-title":"Effects of LSD-25 on relatives of schizophrenic patients","volume":"108","author":"Anastasopoulos","year":"1962","journal-title":"J. Ment. Sci."},{"key":"10.1016\/j.euroneuro.2012.10.006_bib2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0006-3223(94)90044-2","article-title":"Brain 5-HT1A, 5-HT1D, and 5-HT2 receptors in suicide victims","volume":"35","author":"Arranz","year":"1994","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib3","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/archpsyc.1979.01780090013001","article-title":"Neurotransmitter receptors in frontal cortex of schizophrenics","volume":"36","author":"Bennett","year":"1979","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib4","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0893-133X(96)00053-X","article-title":"5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia","volume":"15","author":"Burnet","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib5","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0006-8993(88)91621-6","article-title":"Brain 5-HT2 receptor binding sites in depressed suicide victims","volume":"443","author":"Cheetham","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2012.10.006_bib6","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/0028-3908(84)90100-X","article-title":"Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides","volume":"23","author":"Crow","year":"1984","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1176\/ajp.152.2.197","article-title":"Severity of symptoms in chronically institutionalized geriatric schizophrenic patients","volume":"152","author":"Davidson","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.2003.01693.x","article-title":"The cortical serotonin2A receptor and the pathology of schizophrenia: a likely accomplice","volume":"85","author":"Dean","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2012.10.006_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.schres.2008.06.011","article-title":"Evidence for altered post-receptor modulation of the serotonin 2a receptor in schizophrenia","volume":"104","author":"Dean","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2012.10.006_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0920-9964(96)00034-5","article-title":"Decreased frontal cortical serotonin2A receptors in schizophrenia","volume":"21","author":"Dean","year":"1996","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2012.10.006_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF02815075","article-title":"Decreased serotonin2A receptors in Brodmann's area 9 from schizophrenic subjects. A pathological or pharmacological phenomenon?","volume":"34","author":"Dean","year":"1998","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.euroneuro.2012.10.006_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0166-4328(96)00091-5","article-title":"Serotonin2 receptors and the serotonin transporter in the schizophrenic brain","volume":"73","author":"Dean","year":"1996","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2012.10.006_bib13","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1046\/j.1471-4159.1999.721593.x","article-title":"Changes in serotonin2A and GABA(A) receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex","volume":"72","author":"Dean","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2012.10.006_bib14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.biopsych.2004.10.016","article-title":"Reliability of psychiatric diagnosis in postmortem research","volume":"57","author":"Deep-Soboslay","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0022-3565(24)37560-3","article-title":"Creation of a constitutively activated state of the 5-hydroxytryptamine2A receptor by site-directed mutagenesis: inverse agonist activity of antipsychotic drugs","volume":"286","author":"Egan","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2012.10.006_bib16","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2011.09.055","article-title":"Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs","volume":"147","author":"Fribourg","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature06612","article-title":"Identification of a serotonin\/glutamate receptor complex implicated in psychosis","volume":"452","author":"Gonzalez-Maeso","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tins.2008.12.005","article-title":"Psychedelics and schizophrenia","volume":"32","author":"Gonzalez-Maeso","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.euroneuro.2012.10.006_bib19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-2005-916185","article-title":"Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers","volume":"38","author":"Gouzoulis-Mayfrank","year":"2005","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0006-8993(90)90274-F","article-title":"Autoradiographic analysis of [3H]ketanserin binding in the human brain postmortem: effect of suicide","volume":"507","author":"Gross-Isseroff","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2012.10.006_bib21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0006-8993(90)90081-L","article-title":"Autoradiographic analysis of age-dependent changes in serotonin 5-HT2 receptors of the human brain postmortem","volume":"519","author":"Gross-Isseroff","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2012.10.006_bib22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0006-3223(97)00321-1","article-title":"Alterations in the cortical serotonergic system in schizophrenia: a postmortem study","volume":"42","author":"Gurevich","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib23","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0006-3223(92)90059-9","article-title":"Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: experimental psychosis as a tool for psychiatric research","volume":"32","author":"Hermle","year":"1992","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1176\/ajp.108.8.579","article-title":"Effects of mescaline and lysergic acid (d-LSD-25)","volume":"108","author":"Hoch","year":"1952","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib25","series-title":"Comparative Cytoarchitectonic Atlas of the C57BL\/6 and 129\/Sv Mouse Brains","author":"Hof","year":"2000"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib26","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/mds.23083","article-title":"Increased 5-HT2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations","volume":"25","author":"Huot","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.euroneuro.2012.10.006_bib27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/npp.1993.32","article-title":"Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics","volume":"8","author":"Joyce","year":"1993","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib28","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.pnpbp.2009.04.010","article-title":"Decreased density of serotonin 2A receptors in the superior temporal gyrus in schizophrenia\u2014a postmortem study","volume":"33","author":"Kang","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib29","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/nn.3181","article-title":"HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity","volume":"15","author":"Kurita","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.euroneuro.2012.10.006_bib30","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1001\/archpsyc.1993.01820220066007","article-title":"Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study","volume":"50","author":"Laruelle","year":"1993","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0006-8993(94)90932-6","article-title":"Brain 5-HT2 receptors in suicide victims: violence of death, depression and effects of antidepressant treatment","volume":"642","author":"Lowther","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2012.10.006_bib32","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0197-0186(02)00093-1","article-title":"[3H]-ketanserin binding sites in different psychiatric disorders","volume":"42","author":"Marazziti","year":"2003","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.euroneuro.2012.10.006_bib33","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neulet.2004.12.059","article-title":"5-HT2A and muscarinic receptors in schizophrenia: a postmortem study","volume":"379","author":"Matsumoto","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.euroneuro.2012.10.006_bib34","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.tips.2008.06.007","article-title":"Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions","volume":"29","author":"Millan","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.euroneuro.2012.10.006_bib35","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/0006-3223(86)90332-X","article-title":"Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics","volume":"21","author":"Mita","year":"1986","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","article-title":"Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs","volume":"10","author":"Miyamoto","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib37","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1038\/npp.2011.163","article-title":"Age, sex, and reproductive hormone effects on brain serotonin-1A and serotonin-2A receptor binding in a healthy population","volume":"36","author":"Moses-Kolko","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.biopsych.2005.06.037","article-title":"Higher postmortem prefrontal 5-HT2A receptor binding correlates with lifetime aggression in suicide","volume":"59","author":"Oquendo","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib39","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0140-6736(83)91310-7","article-title":"Brain 5-HT-2 receptors and suicide","volume":"2","author":"Owen","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib40","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/npp.2011.228","article-title":"Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers","volume":"37","author":"Quednow","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/cercor\/5.4.323","article-title":"Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46 and relationship to the Talairach coordinate system","volume":"5","author":"Rajkowska","year":"1995","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/archgenpsychiatry.2009.176","article-title":"Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophrenia","volume":"67","author":"Rasmussen","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib43","first-page":"273","article-title":"Preliminary studies of human cortical 5-HT2 receptors and their involvement in schizophrenia and neuroleptic drug action","volume":"18","author":"Reynolds","year":"1983","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.euroneuro.2012.10.006_bib44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0925-4927(00)00076-7","article-title":"Altered 5-HT(2A) binding sites and second messenger inositol trisphosphate (IP(3)) levels in hippocampus but not in frontal cortex from depressed suicide victims","volume":"99","author":"Rosel","year":"2000","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2012.10.006_bib45","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0893-133X(96)00170-4","article-title":"Serotonin receptors in suicide victims with major depression","volume":"16","author":"Stockmeier","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib46","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1176\/ajp.156.9.1456","article-title":"Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide","volume":"156","author":"Turecki","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib47","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1530-0277.2007.00610.x","article-title":"Family history of alcoholism is associated with lower 5-HT2A receptor binding in the prefrontal cortex","volume":"32","author":"Underwood","year":"2008","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.euroneuro.2012.10.006_bib48","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib49","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1001\/archpsyc.1981.01780280046004","article-title":"Tritiated LSD binding in frontal cortex in schizophrenia","volume":"38","author":"Whitaker","year":"1981","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.10.006_bib50","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1192\/bjp.124.1.64","article-title":"A phenomenological comparison of LSD and schizophrenic states","volume":"124","author":"Young","year":"1974","journal-title":"Br. J. Psychiatry"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X12002854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X12002854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T08:25:50Z","timestamp":1745223950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X12002854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0924977X12002854"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2012.10.006","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysregulated 5-HT2A receptor binding in postmortem frontal cortex of schizophrenic subjects","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2012.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}